Hugh McMullin

Title: Hugh McMullin: Innovator in Recombinant Collagen Production

Introduction

Hugh McMullin is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of collagen through recombinant methods. With a total of 2 patents, McMullin's work has the potential to impact various applications in medicine and tissue engineering.

Latest Patents

McMullin's latest patents focus on methods for the production of gelatin and full-length triple helical collagen in recombinant cells. These methods disclose simplified recombinant production of fibrillar collagens. Specifically, DNAs encoding fibrillar collagen monomers lacking the N propeptide, the C propeptide, or both propeptides are introduced into recombinant host cells and expressed. Trimeric collagen is then recovered from these recombinant host cells, showcasing an innovative approach to collagen production.

Career Highlights

Throughout his career, Hugh McMullin has demonstrated a commitment to advancing biotechnological methods. His patents reflect a deep understanding of molecular biology and the complexities involved in protein production. His work not only contributes to scientific knowledge but also paves the way for practical applications in various industries.

Collaborations

McMullin has collaborated with notable colleagues, including David R Olsen and Robert Tienhan Chang. These partnerships have likely enhanced the scope and impact of his research, fostering innovation in the field.

Conclusion

Hugh McMullin stands out as an influential inventor in the realm of recombinant collagen production. His innovative methods and collaborative efforts continue to shape the future of biotechnology.